News Articles

Press releases are listed below. Please click on a title to read the full text.

05/04/2002	Return of Capital
18/03/2002	Preliminary results for the year ended 31 December 2001
18/03/2002	Biocompatibles Announces Positive Clinical Trial Results
18/03/2002	Biocompatibles Announces Sale of Cardiovascular Stent Business
08/03/2002	Biocompatibles Files for CE Mark Approval for Dextra Stent
08/03/2002	Suspension of patient recruitment in the BRILLIANT II Clinical Trial
04/03/2002	Pre-Market Approval of the Phosphorylcholine (PC)
14/02/2002	RESULT OF EXTRAORDINARY GENERAL MEETING
08/02/2002	Biocompatibles Commences Randomized Trial of 17?-Estradiol Loaded Coronary Stents
23/01/2002	Update on the Status of the Batimastat BiodivYsio Stent IDE Application
15/01/2002	Sale of the Eye Care Division
03/01/2002	Update on Clinical Trial Programme for the Batimastat BiodivYsio Stent
03/01/2002	Pre-Market Approval of the BiodivYsio Small Vessel Over-The-Wire Coronary Stent
24/10/2001	Third Quarter Sales, Current Trading, Product Launches and Drug Delivery Programme Update
21/08/2001	Commencement of clinical trial programme for the Batimastat BiodivYsio? stent
21/08/2001	Start of Clinical Trial for Proclear Compatibles Contact Lenses in Japan
14/08/2001	Interim Results
16/07/2001	AGM Statement
06/07/2001	US launch and Licence Agreements
24/05/2001	Biocompatibles Update on New Product Developments

Showing 161-180 of 204 Page < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

In this section

Read detailed information about the business.